Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BT-5528 by Bicycle Therapeutics for Pancreatic Cancer: Likelihood of Approval
BT-5528 is under clinical development by Bicycle Therapeutics and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...
BT-5528 by Bicycle Therapeutics for Esophageal Cancer: Likelihood of Approval
BT-5528 is under clinical development by Bicycle Therapeutics and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase...
BT-5528 by Bicycle Therapeutics for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
BT-5528 is under clinical development by Bicycle Therapeutics and currently in Phase II for Transitional Cell Cancer (Urothelial Cell Cancer)....
BT-5528 by Bicycle Therapeutics for Ovarian Cancer: Likelihood of Approval
BT-5528 is under clinical development by Bicycle Therapeutics and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...
BT-5528 by Bicycle Therapeutics for Bladder Cancer: Likelihood of Approval
BT-5528 is under clinical development by Bicycle Therapeutics and currently in Phase II for Bladder Cancer. According to GlobalData, Phase...
BT-5528 by Bicycle Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
BT-5528 is under clinical development by Bicycle Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...